Literature DB >> 9353100

Hodgkin's disease of the esophagus.

A B Gelb1, L J Medeiros, Y Y Chen, L M Weiss, N Weidner.   

Abstract

A 61-year-old man with acquired immunodeficiency syndrome (AIDS) sought care because of the onset of progressive dysphagia. He was found to have a perforated, fungating esophageal mass. The combined histologic and immunologic findings were diagnostic of Hodgkin's disease, nodular sclerosis type, lymphocyte-depleted variant, arising in the esophagus. The Reed-Sternberg cells and mononuclear variants were positive for Epstein-Barr virus (EBV) latent membrane protein (LMP1) and EBV RNA. Occasional small lymphoid cells were also positive for EBV RNA. Polymerase chain reaction studies demonstrated the presence of EBV type A without deletion of the EBV LMP1 gene. Other authors have reported an increased frequency of type B EBV and deletion of the EBV LMP1 gene in cases of human immunodeficiency virus-associated Hodgkin's disease. Hodgkin's disease arising in the esophagus is rare in immunocompetent patients. However, in the presence of AIDS, Hodgkin's disease should be considered in the differential diagnosis of patients with signs or symptoms of esophageal disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9353100     DOI: 10.1093/ajcp/108.5.593

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  2 in total

1.  A definitive diagnosis of primary Hodgkin lymphoma on endoscopic biopsy material utilizing in-depth immunohistochemical analysis.

Authors:  Garnet Horne; Shaun A C Medlicott; Adnan Mansoor; Johan Lategan; Raymond Lai; P Beck
Journal:  Can J Gastroenterol       Date:  2007-03       Impact factor: 3.522

Review 2.  A case of primary low grade mucosa associated lymphoid tissue (MALT) lymphoma of the oesophagus.

Authors:  S Hosaka; N Nakamura; T Akamatsu; T Fujisawa; Y Ogiwara; K Kiyosawa; E Hidaka; H Ota; T Katsuyama; H Inagaki
Journal:  Gut       Date:  2002-08       Impact factor: 23.059

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.